George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
It’s likely many individuals involved with this article have a conflict of interest.
For me the fact they say SNG001 has a place at all as a therapeutic means it was likely a resounding success in all trials to date……..
GLA
Correct Ivermectin is not an approved drug for covid in Japan. However doctors in Japan are apparently allowed to prescribe a number of off-label drugs.
https://peckford42.wordpress.com/2021/08/28/greenlight-for-ivermectin-in-japan/
Awhatsup - I agree with your thinking on Fauci. Work with interferon beta 1a has been ongoing since the early AIDS days and the leaders of that research know it works. JM, a nemesis of Fauci, mentioned interferon beta 1a by name in spray form way over a year ago and that led me to this site and investment. I personally think SNG001 was under the radar at that time and is being deliberately held back. Great respect for RM and the BoD as they must feel they are walking a mine field of trip wires. Everyone is entitled to their view on vaccines, but to hold back a therapy, should that be the case, is just evil. How much longer will it be before the delay generates it's own conspiracies.... We'll all be labelled at that point....
IMHO GLA
there are those that research the product in great detail as well as its competitors. Their knowledge and confidence in the product is amazing and I can understand their natural respect for those leading the way.
However, there are those researching why SNG001 is being ignored. Asking why a therapeutic has done two P2 trials, waited a full term for peer review, and been drawn into silence over long Covid without having EUA.
There are those that quite rightly follow the science, and there are those that follow the money. Science should win every time, but the longer SNG001 is ignored by government and MSM the more questions will be asked.
If SNG001 is at sufferance in order to push vaccines and vaccine passports around the world, one must ask why and ask how many are they prepared to let die before SNG001 gets recognition.
Dr Fauci’s accountability will remain in question whilst the two groups remain divided.
Hopefully very soon we will get the eagerly awaited RNS that will put all this behind us, but should we go further into P3 without EUA both sides will remain aggrieved.
DYOR & GLA
Woodstock:
I do wish people would stop saying deaths from covid. The numbers quoted are deaths with positive covid pcr test within 28 of passing, the majority being aged with morbidities.
I've been invested in Synairgen for well over a year and have great confidence in the product and team. However, the more hurdles we have to jump the more one thinks Big Pharma do not want therapeutics out there. Vaccination should always be the choice of the receiver.
I don't have data to prove but my understanding is the vast majority of vaccine adverse reactions are not reported via the UK's VAERS system, yet the the governments own figures for Covid vaccines as of the 19th May are:
246,276 - Reports
857,323 - Adverse reactions
1,192 - Deaths
The therapeutics I believe should be in circulation worldwide are - SNG001, HCQ & Ivermectin
DYOR & GLA
SNG was my first investment. I listened to senior virologist J*** M******* early in 2020 (she's certainly no fan of Fauci). Her statement that 'they would be fine as she had her Interferon beta 1a spray in the fridge'! Googled Interferon beta 1a and found Synairgen. First investment of £25k at 54p and been slowly building since as have massive confidence in the product and team.
She says it's still in the fridge..... I wonder if Fauci has also known all along..... wouldn't surprise me one bit.....
GLA
Looked up Bemcentinib and found the following, looks like the trials have been stopped.
BerGenBio notes the UK Research and Innovation’s (UKRI) decision to cease the grant funding to the University Hospital Southampton NHS Trust for the COVID-19 ACCORD clinical study in which BerGenBio’s bemcentinib was the lead drug candidate to be tested.
https://nordiclifescience.org/update-on-bemcentinibs-involvement-in-potential-covid-19-treatment/
Dumbpunter,
Apologies as I seem to have annoyed you…..
That was my point, SNG recognition in US but no real recognition in the UK, many on here have commented on the lack of government recognition / action.
The NIH document does recommend against the use of interferons outside of clinical trials, but it is a month out of date…… I assume that’s the warning you’re referring to.
Have a good weekend
Sorry guys if this link has already been posted.
My search on interferons using google first listed Remdesivir combined with INF. However using duckduckgo the first result was the following:
https://www.covid19treatmentguidelines.nih.gov/immune-based-therapy/immunomodulators/interferons/
Under NIH 'Whats New' Clinical Data for Covid-19, inhaled interferon was the first treatment listed with SNG trial details stated, must be their most likely, and Synairgen with SNG001 trial results were noted in the reference...... This release was dated 27 August 2020
IMO when the Government borrows such vast sums from the world banks (mostly big pharma money) Boris has to follow orders – Somehow we need to embarrass government into recognising SNG and taking action to ‘save lives and protect the NHS’ (sounds familiar)
GLA
Sorry for such a long post, but I've been sitting on the outside for some time now...
I put my faith and money in Synairgen many months ago. In the early days we had lots of research data, including China’s excellent January trials with INF on its front line medical staff. Should any doubt remain look behind the so called ‘curtain’ and check out China’s collaboration with Cuba. Cuba has an impressive pharmaceutical record and is producing its own treatments.
Cuba has a population over 11m and its reported death tally for Covid19 stands at just 115. Their own treatment is ‘Cuban interferon alpha 2b’ developed over the last 30 years.
The SNG001 treatment is best used at the start of infection, so we’re all expecting the home trial results to be better than the hospital trials…. but my dilemma is how easily big pharma has managed to write off hydroxychloroquine, and are they doing the same with SNG001, for them it’s all about the vaccine. I don’t think it unreasonable to assume that individuals with the expertise and recognition required to peer review our results of nine weeks ago are in some way indebted to big pharma, hence no publication.
Since our results big pharma have tried to rescue their own therapeutic Remdesivir by prescribing it together with INF, although nowhere near as good as SGN001 it will have a positive effect.
All governments across the UN appear to be doing and saying the same thing, and seem unable to push therapeutics, only vaccines. The delay in getting SNG001 out into the market place is going to cost many many lives. How is the knowledge of SNG001 best put into the public domain? Maybe the embarrassment will force government to act sooner rather than later…
GLA & DYOR